Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022-Reference-Cited by-同舟云学术

Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022

Published:2024-01-25 Issue:2 Volume:17 Page:189-201
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Du Yikuan¹,Zhu Jinfeng²,Guo Zhuoming²,Wang Zhenjie²,Wang Yuni²,Hu Mianda²,Zhang Lingzhi²,Yang Yurong²,Wang Jinjin²,Huang Yixing²,Huang Peiying²,Chen Mianhai²,Chen Bo²,Yang Chun²

Affiliation:

1. Central Laboratory, The Tenth Affiliated Hospital of Southern Medical University, Dongguan, People’s Republic of China

2. Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, The First Dongguan Affiliated Hospital, School of Basic Medical Sciences, Guangdong Medical University, Dongguan, China

Funder

Natural Science Foundation of Guangdong Province

Dongguan Science and Technology of Social Development Program

Research and Development Fund of Dongguan People’s Hospital

Guangdong Medical University Students’ Innovation Experiment Program

Guangdong Medical University Students’ Innovation and Entrepreneurship Training Program

Provincial and National College Students’ Innovation and Entrepreneurship Training Program

Guangdong Medical University-Southern Medical University twinning research team project

Cai Limin National Traditional Chinese Medicine Inheritance Studio

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2306223

Reference83 articles.

1. Metformin and Its Benefits for Various Diseases

2. Metformin: historical overview

3. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis

4. Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis

5. Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety assessment of Yasmin: Real-world adverse event analysis using the FAERS database;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-10

2. Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database;Heliyon;2024-09

3. Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database;Frontiers in Pharmacology;2024-08-23

4. Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024;2024-08-22

5. A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-08-12